Elevated homocysteine levels contribute to larger hematoma volume in patients with intracerebral hemorrhage

Journal of Stroke and Cerebrovascular Diseases

Volumn 24, Issue 4, 2015, Pages 784-788

  Zhou, Fangfang ^a   Chen, Botao ^b   Chen, Chunli ^a   Huang, Jinjin ^a   Chen, Shiyu ^a   Guo, Fulin ^b   Hu, Zhiping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Hematoma; Homocysteine; Intracerebral hemorrhage; Stroke; Stroke outcome

Indexed keywords

HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; FEMALE; HEMATOMA; HOSPITAL ADMISSION; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; AGED; BLOOD; CHI SQUARE DISTRIBUTION; COMPLICATION; LEUKOCYTE COUNT; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; THALAMUS;

AGED; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; FEMALE; HEMATOMA; HOMOCYSTEINE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THALAMUS;

EID: 84933278230     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.11.005     Document Type: Article

References (44)

1. Ikram MA, Wieberdink RG, Koudstaal PJ. International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 2012;14:300-306.
2. Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987-993.
3. Jordan LC, Kleinman JT, Hillis AE. Intracerebral hemorrhage volume predicts poor neurologic outcome in children. Stroke 2009;40:1666-1671.
4. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
5. McCully KS. Homocysteine and vascular disease. Nat Med 1996;2:386-389.
6. Collaboration HS. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288:2015-2022.
7. Kwon H-M, Lee Y-S, Bae H-J, et al. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke 2014;45:871-873.
8. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: From basic science to clinical evidence. Thromb Haemost 2005;94:907-915.
9. Hwang IK, Yoo KY, Suh HW, et al. Folic acid deficiency increases delayed neuronal death, DNA damage, platelet endothelial cell adhesion molecule-1 immunoreactivity, and gliosis in the hippocampus after transient cerebral ischemia. J Neurosci Res 2008;86:2003-2015.
10. Li Z, Sun L, Zhang H, et al. Elevated plasma homocy steine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene c677t polymorphism was a risk factor for thromboticstroke a multicenter case-control study in China. Stroke 2003;34:2085-2090.
11. Hofmann MA, Lalla E, Lu Y, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001;107:675-683.
12. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma a potential mechanism of lesion stabilization. Circulation 1998; 97:2433-2444.
13. Mach F, Schönbeck U, Bonnefoy J-Y, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40 induction of collagenase, stromelysin, and tissue factor. Circulation 1997;96:396-399.
14. Rosell A, Ortega-Aznar A, Alvarez-Sabín J, et al. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006;37:1399-1406.
15. Silva Y, Leira R, Tejada J, et al. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005;36:86-91.
16. Alam MM, Mohammad AA, Shuaib U, et al. Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis. J Cereb Blood Flow Metab 2009; 29:157-165.
17. Béjot Y, Aboa-Eboule C, Hervieu M, et al. The deleterious effect of admission hyperglycemia on survival and functional outcome in patients with intracerebral hemorrhage. Stroke 2012;43:243-245.
18. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304-1305.
19. Ke XD, Foucault-Bertaud A, Genovesio C, et al. Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism. Mol Cell Biochem 2010; 335:203-210.
20. Gryglewski R, Palmer R, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456.
21. Winkler BS, Orselli SM, Rex TS. The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Radic Biol Med 1994; 17:333-349.
22. Kanani PM, Sinkey CA, Browning RL, et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999;100:1161-1168.
23. Wall RT, Harlan JM, Harker LA, et al. Homocysteineinduced endothelial cell injury in vitro: A model for the study of vascular injury. Thromb Res 1980;18:113-121.
24. Blundell G, Jones BG, Rose FA, et al. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 1996;122:163-172.
25. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370.
26. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996;98:5.
27. Upchurch GR, Welch GN, Fabian AJ, et al. Homocyst(e) ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272:17012-17017.
28. Lee KR, Kawai N, Kim S, et al. Mechanisms of edema formation after intracerebral hemorrhage: Effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 1997;86:272-278.
29. Hamann GF, Okada Y, Fitridge R, et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995;26:2120-2126.
30. Horstmann S, Kalb P, Koziol J, et al. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients influence of different therapies. Stroke 2003; 34:2165-2170.
31. Aoki T, Sumii T, Mori T, et al. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 2002;33:2711-2717.
32. Forsyth KD, Levinsky RJ. Fibronectin degradation; an invitro model of neutrophil mediated endothelial cell damage. J Pathol 1990;161:313-319.
33. Chaussalet M, Lamy E, Foucault-Bertaud A, et al. Homocysteine modulates the proteolytic potential of human vascular endothelial cells. Biochem Biophys Res Commun 2004;316:170-176.
34. Faßbender K, Mielke O, Bertsch T, et al. Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999;353:1586-1587.
35. Viswanathan A, Greenberg SM. Intracerebral hemorrhage. Handb Clin Neurol 2008;93:767-790.
36. Vtnters H. Cerebral amyloid angiopathy: A critical review. Stroke 1987;18:311-324.
37. Arakawa S, Saku Y, Ibayashi S, et al. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998;29:1806-1809.
38. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000;342:240-245.
39. Matsui T, Arai H, Yuzuriha T, et al. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke 2001;32:1116-1119.
40. Feng C, Bai X, Xu Y, et al. Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease. Int J Med Sci 2013;10:408.
41. Outinen PA, Sood SK, Pfeifer SI, et al. Homocysteineinduced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 1999; 94:959-967.
42. Mendoza-Oliva A, Ferrera P, Arias C. Interplay between cholesterol and homocysteine in the exacerbation of amyloid-beta toxicity in human neuroblastoma cells. CNS Neurol Disord Drug Targets 2013;12:842-848.
43. Kazui S, Minematsu K, Yamamoto H, et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997;28:2370-2375.
44. Meiklejohn D, Vickers M, Dijkhuisen R, et al. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 2001;32:57-62.